What is the range of opportunities for patient foundations to support more rapid and effective clinical research, through preference studies and other patient insights, trial design and networks, recruitment and retention? Is there a role for patient groups in promoting and enabling Quality by Design?

Moderator

Zach Hallinan
Project Manager, CTTI

Speakers

Ron Bartek
President, Friedreich’s Ataxia Research Alliance

Jaye Bea Smalley
Head of Patient Advocacy, Immunovant

Lynne Quittell
Medical Consultant, Cystic Fibrosis Foundation

This recording is from the TRAIN workshop held on November 8, 2021 entitled 'Foundations’ Role in Supporting Clinical Trial Innovation' that was collaboratively run by FasterCures and the Clinical Trial Transformation Initiative (CTTI).